1971:	Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification. European Journal of Immunology (with M. Gafni, D. Givol, and M. Sela)
1974:	Ferritin, a Hodgkin's disease associated antigen. Proceedings of the National Academy of Sciences (with S. E. Order, and D. H. Katz).
1980:	Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten: an esterase-like activity of the antibody-containing site? FEBS Letters (with F. Kohen, J. B. Kim, H. R. Lindner and B. Green)
1981:	Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro. Proceedings of the National Academy of Sciences (with Y. Kaufmann, and G. Berke)
1985:	Variability and repertoire size of T-cell receptor V alpha gene segments. Nature (with D. M. Becker and others)
1989:	Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proceedings of the National Academy of Sciences (with G. Gross and T. Waks)
1990:	Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity. Biochemistry (with D. Tawfik, R. R. Zemel, R. Arad-Yellin, and B. S. Green)
1993:	Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proceedings of the National Academy of Sciences (with T. Waks, G. Gross, and D. G. Schindler)
1995:	In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Research (with P. Hwu and others)
2004:	Adoptive Immunotherapy of Prostate Cancer Bone Lesions Using Redirected Effector Lymphocytes. Journal of Clinical Investigation (with J. Pinthus and others)
2011:	Redirected tumor-specific allogeneic T cells for universal treatment of cancer. Blood (with A. Marcus and T. Waks)
2012:	Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice. Gastroenterology (with A. Maliar and others)
2014:	Adoptive cell therapy of spontaneously progressing mammary cancer model. Molecular Therapy (with A. Globerson and T. Waks)
2014:	Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T Cells. Molecular Therapy (with D. Blat and T. Waks)